Back to calendar
Coherus Oncology, Inc. (CHRS) Earnings
CHRS reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.24
Actual EPS: $-0.27
EPS surprise: -2.53%
Company overview
Market Cap$237.5M
PriceUSD 1.54
EPS (TTM)-1.25
52-week high2.62
52-week low0.81
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees147